Picture EBD Group BioPharm America 2018 Boston September 600x60px
Document › Details

Bruker Corporation. (10/13/15). "Press Release: Bruker Announces René Lenggenhager as BioSpin Group President". Billerica, MA.

Organisations Organisation Bruker BioSpin (Operating Business of Bruker Corporation)
  Group Bruker Corporation (Group)
  Organisation 2 Mettler-Toledo (Schweiz) AG
  Group Mettler-Toledo (Group)
Product Product analytical instrument
Persons Person Lenggenhager, René (Bruker Corp 201511– President of BioSpin Group before Mettler Toledo since 2000 before Siemens)
  Person 2 Laukien, Frank H. (Bruker 201204 President + CEO)

Bruker today announces the appointment of Dr. René Lenggenhager as President of the Bruker BioSpin Group, effective November 1st, 2015. René has over 25 years of management experience in international high-tech companies and in the scientific instruments industry, where his responsibilities have included general management with P&L responsibility for a global business, marketing, R&D and global operations. René has extensive experience with complex transformations, operational excellence, lean manufacturing, marketing and value selling. Moreover, René has a very successful track record in sustainable, profitable growth with a focus on customers and innovation.

Since 2004, Dr. Lenggenhager has served as General Manager for Laboratory Weighing at METTLER TOLEDO (MTD). From 2000 until 2003, he was the Head of R&D of Laboratory & Weighing Technologies at MTD. Previously, he worked at the Siemens Building Technologies SBT Cerberus Division, at Cerberus AG, at Landis & Gyr AG and at Metrohm AG. René holds a Ph.D. in physics from the Swiss Federal Institute of Technology (ETH), Zurich, a Bachelor of Science in electronics from the University of Applied Sciences NTB, Buchs, and an Executive MBA from University of St. Gallen, all in Switzerland.

Frank Laukien, President and CEO of Bruker Corporation, said: “I am very pleased to welcome René to Bruker. His success in our industry, his broad technical background, and his passion for innovation and customers are impressive. His outstanding track record with operational excellence, profitable growth and margin enhancement make René a compelling Group President to lead Bruker BioSpin to the next level.”

Dr. René Lenggenhager commented: “Bruker has a strong reputation for excellence in the customer community, with high-performance instruments and high-value analytical solutions. Bruker BioSpin is making progress with its transformation and recent new product launches, and I am excited to join this creative team to drive profitable growth and value for our customers and shareholders. I am committed to business success and to providing the best solutions to make our customers successful, and to develop new applications that will improve the quality of human life.”

About Bruker Corporation (NASDAQ: BRKR)

For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics.

For more information, please visit:

View source version on

Source: Bruker Corporation

Media Contact:

Bruker Corporation
Dr. Thorsten Thiel, 49 (721) 5161 – 6500
Director of Marketing Communications


Investor Contact:

Bruker Corporation
Joshua Young, 1-978-667–9580, ext. 1479
Vice President, Investor Relations

Record changed: 2016-01-10


Picture [LSE] – The Business Web Portal 600x80px

More documents for Bruker Corporation (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BioPharm America 2018 Boston September 600x60px

» top